Division of Infectious Diseases

David Aronoff, MD, Addison B. Scoville Jr. Professor of Medicine and director of the Division of Infectious Diseases, is departing Vanderbilt University Medical Center to become chair of the Department of Medicine at Indiana University School of Medicine.

A report of more than 23,000 health care workers and employees at Vanderbilt University Medical Center who received the Pfizer-BioNTech mRNA COVID-19 vaccine shows that a risk stratification screening mechanism for potential allergies to the vaccine worked exceedingly well as the vaccine program rolled out in December 2020.

Hospital data from a CDC network that monitors influenza revealed that adults hospitalized for COVID-19 in the early months of the pandemic were 20x more likely to die compared to hospitalized influenza patients.

Two physician-scientist Instructors in Medicine at Vanderbilt University Medical Center (VUMC) — Jeeyeon Cha, MD, PhD, and Celestine Wanjalla, MD, PhD — are among 12 recipients of the 2021 Burroughs Wellcome Fund (BWF) Career Award for Medical Scientists.

Titus Daniels, MD, MPH, MMHC, has returned to Vanderbilt University Medical Center; he was previously on the faculty from 2007 to 2017.

Under the SARS CoV-2 Return to School Saliva Opt-in Screening Study, which began last November at University School of Nashville, a research team from Vanderbilt University Medical Center is testing a solution for efficient asymptomatic disease surveillance and control.

In HIV-positive individuals with diabetes, immune cells in fat are more proinflammatory and cytotoxic and may represent a therapeutic target for diabetes.